https://www.selleckchem.com/pr....oducts/sivelestat-so
60 % overall prevalence for moderate/severe PH was estimated in this cohort of WHWTs presented with CIPF vs. 5 % in CTRLS (P = 0.0002). The presence of moderate/severe PH at initial presentation was not associated with survival. Results of the present study confirm a high prevalence of PH at diagnosis in WHWTs affected with CIPF and highlight the utility of PV/PA as a non-invasive surrogate for assessment of PH in this population. Results of the present study confirm a high prevalence of PH at diagnosis in WHWTs affected with
Like
Comment
Share
